Acute Kidney Injury Associated with Synthetic Cannabinoid Use — Multiple States, 2012 (report – 2013)http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6206a1.htm

First Metabolic Profile of XLR-11, a Novel Synthetic Cannabinoid, Obtained by Using Human Hepatocytes and High-Resolution Mass Spectrometry (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24014837

Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23916483

Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24418231

Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: A snapshot of the German situation in the autumn of 2012 (full – 2014) http://onlinelibrary.wiley.com/doi/1.../dta.1499/full

Quantitative Measurement of XLR11 and UR-144 in Oral Fluid by LC-MS-MS (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24812645

Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection of Use of the Synthetic Cannabinoid Agonists UR-144 and XLR-11 in Human Urine (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24908262

Acute kidney injury associated with smoking synthetic cannabinoid (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25089722

Driving Under the Influence of Synthetic Cannabinoid Receptor Agonist XLR-11 (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25088081